NLICC 2025 is proud to collaborate with leading organizations dedicated to advancing liver health. These partnerships are essential to fostering innovation, knowledge sharing, and impactful initiatives that improve patient care and outcomes. We are grateful for their support in making this conference a success.
The Egyptian Drug Authority (EDA)
The Egyptian Drug Authority (EDA) joins NLICC 2025 as a key collaborator, bringing its expertise in regulating and monitoring pharmaceuticals and medical devices. This partnership strengthens the conference’s focus on translating research into safe and effective treatments for liver diseases.
The Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Society of Radiology & Nuclear Medicine (ESRNM) joins NLICC 2025 as a valued partner, bringing its expertise in radiology and nuclear medicine to the forefront of the conference. This collaboration strengthens the conference’s focus on utilizing advanced imaging techniques for accurate diagnosis and effective treatment of liver diseases.
The Egyptian Society of Medical Microbiology
The Egyptian Society of Medical Microbiology proudly joins NLICC 2025 as a key collaborator, bringing its expertise in microbiology and immunology to the forefront of liver health. This Collaboration enhances the conference’s focus on understanding the complex interplay between microbial infections, the immune system, and liver disease. By fostering collaboration between hepatologists and microbiologists, NLICC 2025 aims to advance research, improve diagnostic techniques, and optimize treatment strategies for liver conditions related to infectious agents.